Evidence map›Paper›PMID 33170168›Full record

ArticleActa bio-medica : Atenei Parmensis2020

Bacteriophages in food supplements obtained from natural sources.

Aysha Karim Kiani, Kyrylo Anpilogov, Astrit Dautaj, Giuseppe Marceddu, Willy Nelson Sonna, Marcella Percio, Munis Dundar, Tommaso Beccari, Matteo Bertelli

Abstract read
In one paragraph

Article in Acta bio-medica : Atenei Parmensis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. The future of phage therapy in the USA.Trends in molecular medicine · 2025
    Review
  2. Article
  3. Methods of Controlling Microbial Contamination of Food.Pathogens (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aysha Karim KianiAllama Iqbal Open University, Islamabad, Pakistan; MAGI EUREGIO, Bolzano, Italy. ayshakiani@gmail.com.
Kyrylo AnpilogovMAGI EUREGIO, Bolzano, Italy. kirill.anpilogov@assomagi.org.
Astrit DautajEBTNA-LAB, Rovereto (TN), Italy. astrit.dautaj@assomagi.org.
Giuseppe MarcedduMAGI EUREGIO, Bolzano, Italy. giuseppe.marceddu@assomagi.org.
Willy Nelson SonnaMAGI EUREGIO, Bolzano, Italy. willy.nelson@assomagi.org.
Marcella PercioMAGI'S LAB, Rovereto (TN), Italy. marcella.percio@assomagi.org.
Munis DundarDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey. dundar@erciyes.edu.tr.
Tommaso BeccariDepartment of Pharmaceutical Sciences, University of Perugia, Perugia, Italy. tommaso.beccari@unipg.it.
Matteo BertelliMAGI EUREGIO, Bolzano, Italy; EBTNA-LAB, Rovereto (TN), Italy; MAGI'S LAB, Rovereto (TN), Italy. matteo.bertelli@assomagi.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human gastrointestinal tract is colonized by bacteria that constitute the interstinal microbiota. Changes in the microbiota may lead to several chronic disorders. Bacteriophages are viruses that specifically target bacteria. Several food components contain bacteriophages and probiotics. Bacteriophages have a great specificity for harmful bacteria, helping the growth of good bacteria. Because of their qualities, bacteriophages are considered beneficial component of probiotics that target the pathogenic bacteria and support the natural human microbiota.

Indexed as

BacteriophagesProbioticsBacteriaGastrointestinal TractHumans

Identifiers

PMID33170168
PMCPMC8023131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.